Page 84 - OR-1-2
P. 84

Trends Mol Med. 2020;26(3):273-284.           190. Mulder LA, Depla JA, Sridhar A, Wolthers K, Pajkrt D, Vieira
                                                                 de Sa R. A beginner’s guide on the use of brain organoids
                doi: 10.1016/j.molmed.2019.09.010
                                                                 for neuroscientists: A systematic review. Stem Cell Res Ther.
            179. Mulay AR, Hwang J, Kim DH. Microphysiological blood-  2023;14(1):87.
                brain barrier systems for disease modeling and drug
                development. Adv Healthc Mater. 2024;13(21):e2303180.     doi: 10.1186/s13287-023-03302-x
                                                              191. Lahimchi MR, Maroufi  F,  Maali  A.  Induced  pluripotent
                doi: 10.1002/adhm.202303180
                                                                 stem cell-derived chimeric antigen receptor T cells:
            180. Hussain B, Fang C, Chang J. Blood-brain barrier breakdown:   The intersection of stem cells and immunotherapy.  Cell
                An emerging biomarker of cognitive impairment in normal   Reprogram. 2023;25(5):195-211.
                aging and dementia. Front Neurosci. 2021;15:688090.
                                                                 doi: 10.1089/cell.2023.0041
                doi: 10.3389/fnins.2021.688090
                                                              192. Tahbaz M, Yoshihara E. Immune protection of stem
            181. Ko EC, Spitz S, Pramotton FM, et al. Accelerating the in vitro   cell-derived islet cell therapy for treating diabetes.  Front
                emulation of Alzheimer’s disease-associated phenotypes   Endocrinol (Lausanne). 2021;12:716625.
                using a novel 3D blood-brain barrier neurosphere co-culture      doi: 10.3389/fendo.2021.716625
                model. Front Bioeng Biotechnol. 2023;11:1251195.
                                                              193. Petrus-Reurer S, Romano M, Howlett S, Jones JL,
                doi: 10.3389/fbioe.2023.1251195                  Lombardi G, Saeb-Parsy K. Immunological considerations
            182. Song G, Zhao M, Chen H,  et al. The application of brain   and challenges for regenerative cellular therapies. Commun
                organoid technology in stroke research: Challenges and   Biol. 2021;4(1):798.
                prospects. Front Cell Neurosci. 2021;15:646921.     doi: 10.1038/s42003-021-02237-4
                doi: 10.3389/fncel.2021.646921                194. Gravina A, Tediashvili G, Zheng Y, et al. Synthetic immune
            183. Nzou G, Wicks RT, VanOstrand NR,  et al. Multicellular   checkpoint engagers protect HLA-deficient iPSCs and
                3D neurovascular unit model for assessing hypoxia   derivatives from innate immune cell cytotoxicity. Cell Stem
                and neuroinflammation induced blood-brain barrier   Cell. 2023;30(11):1538-1548.e4.
                dysfunction. Sci Rep. 2020;10(1):9766.           doi: 10.1016/j.stem.2023.10.003
                doi: 10.1038/s41598-020-66487-8               195. Urzì O, Gasparro R, Costanzo E, et al. Three-dimensional
            184. Grebenyuk S, Ranga A. Engineering organoid vascularization.   cell cultures: The bridge between in vitro and in vivo models.
                Front Bioeng Biotechnol. 2019;7:39.              Int J Mol Sci. 2023;24(15):12046.
                doi: 10.3389/fbioe.2019.00039                    doi: 10.3390/ijms241512046
            185. Mo F, Pellerino A, Soffietti R, Ruda R. Blood-brain barrier   196. Yang G, Mahadik B, Choi JY, Fisher JP. Vascularization in
                in brain tumors: Biology and clinical relevance. Int J Mol Sci.   tissue engineering: Fundamentals and state-of-art.  Prog
                2021;22(23):12654.                               Biomed Eng (Bristol). 2020;2(1):012002.
                doi: 10.3390/ijms222312654                       doi: 10.1088/2516-1091/ab5637
            186. Bergmann  S,  Lawler  SE,  Qu  Y,  et al.  Blood-brain-barrier   197. Lancaster MA, Knoblich JA. Generation of cerebral
                organoids for investigating the permeability of CNS   organoids  from  human  pluripotent  stem  cells.  Nat Protoc.
                therapeutics. Nat Protoc. 2018;13(12):2827-2843.  2014;9(10):2329-2340.
                doi: 10.1038/s41596-018-0066-x                   doi: 10.1038/nprot.2014.158
            187. Hong SJ, Bock M, Zhang S, An SB, Han I. Therapeutic   198.  Lou YR, Leung AW. Next generation organoids for biomedical
                transplantation of human central nervous system organoids   research and applications. Biotechnol Adv. 2018;36(1):132-149.
                for neural reconstruction. Int J Mol Sci. 2024;25(15):8540.     doi: 10.1016/j.biotechadv.2017.10.005
                doi: 10.3390/ijms25158540                     199. Wimmer RA, Leopoldi A, Aichinger M, et al. Human blood
            188. Wang SN, Wang Z, Xu TY, Cheng MH, Li WL, Miao CY.   vessel organoids as a model of diabetic vasculopathy. Nature.
                Cerebral organoids repair ischemic stroke brain injury.   2019;565(7740):505-510.
                Transl Stroke Res. 2020;11(5):983-1000.          doi: 10.1038/s41586-018-0858-8
                doi: 10.1007/s12975-019-00773-0               200.  Marton RM, Pasca SP. Organoid and assembloid technologies
            189. Cao SY, Tao MD, Lou SN, et al. Functional reconstruction   for investigating cellular crosstalk in human brain development
                of the impaired cortex and motor function by hMGEOs   and disease. Trends Cell Biol. 2020;30(2):133-143.
                transplantation in stroke.  Biochem Biophys Res Commun.      doi: 10.1016/j.tcb.2019.11.004
                2023;671:87-95.
                                                              201. Bhaduri A, Andrews MG, Mancia Leon W, et al. Cell stress in
                doi: 10.1016/j.bbrc.2023.06.010                  cortical organoids impairs molecular subtype specification.


            Volume 1 Issue 2 (2025)                         35                                doi: 10.36922/or.8162
   79   80   81   82   83   84   85   86   87   88   89